Latest California Healthline Stories
KHN Midwest editor and correspondent Laura Ungar shares her expertise on Vice President Mike Pence’s public health track record as he leads the nation’s novel coronavirus response. Ungar covered a 2015 Indiana HIV outbreak and its fallout amid Pence’s tenure as governor.
Kaiser Health News senior correspondent Sarah Varney and PBS NewsHour producer Jason Kane report from Tennessee, where the rate of uninsured kids has soared.
A routine doctor’s visit for a sore throat brought more than $28,000 in charges for one New York City woman in our latest “Bill of the Month” installment.
One out of every 13 seniors in America struggles to get enough food to eat while the federal program intended to help hasn’t kept pace with the graying population. KHN Midwest editor/correspondent Laura Ungar explains what you need to know about this largely hidden problem.
Politicians are throwing around a lot of terms when they talk about their health care plans: universal care, “Medicare for All,” “Medicare Buy-In.” KHN helps explain what they are talking about.
After journalists investigate, Fresenius, one of the largest dialysis providers in the U.S., has agreed to waive a half-million-dollar bill. Sovereign Valentine, from Plains, Mont., said it’s a “huge relief.”
The U.S. government claimed that turning American medical charts into electronic records would make health care better, safer and cheaper. Ten years and $36 billion later, the system is an unholy mess. Inside a digital revolution that took a bad turn.
KHN correspondent Emmarie Huetteman appeared on the C-SPAN program “Washington Journal,” where she fielded viewers’ calls about high drug prices and industry criticism.
Most hearings before the U.S. House and Senate are routine affairs. But a few tense moments featuring everyone from Hillary Clinton to tobacco CEOs drew the attention of millions of Americans.
The Food and Drug Administration is supposed to inspect all factories, foreign and domestic, that produce drugs for the U.S. market. But a KHN review of thousands of FDA documents — inspection records, recalls, warning letters and lawsuits — reveals how drugs that are poorly manufactured or contaminated can reach consumers.